Lacey David L. — SEC Form 4 filings

SEC reporting owner CIK 1734422. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-05-20 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcus Biosciences, Inc. (RCUS)Director47
Nurix Therapeutics, Inc. (NRIX)Director33

Form 4 filings — Lacey David L.

FiledFormIssuerReported transactionsSource
2026-06-124Arcus Biosciences, Inc. (RCUS)Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0EDGAR
2026-05-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 31,250 (derivative) @ $0EDGAR
2025-06-124Arcus Biosciences, Inc. (RCUS)Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0EDGAR
2025-05-194Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-01-274Arcus Biosciences, Inc. (RCUS)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2024-06-074Arcus Biosciences, Inc. (RCUS)Grant/award (A): 8,400 @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR
2024-05-204Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734422 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →